553
Views
12
CrossRef citations to date
0
Altmetric
Review

Non-clinical studies of progesterone

Pages 315-320 | Received 22 Mar 2018, Accepted 09 Apr 2018, Published online: 23 May 2018

References

  • Conneely OM, Lydon JP. Progesterone receptors in reproduction: functional impact of the A and B isoforms. Steroids 2000;65:571–7
  • Conneely OM, Mulac-Jericevic B, Lydon JP, et al. Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice. Mol Cell Endocrinol 2001;179:97–103
  • Conneely OM, Mulac-Jericevic B, Lydon JP. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids 2003;68:771–8
  • Nutu M, Weijdegard B, Thomas P, et al. Membrane progesterone receptor gamma: tissue distribution and expression in ciliated cells in the fallopian tube. Mol Reprod Dev 2007;74:843–50
  • Hochner-Celnikier D, Marandici A, Iohan F, et al. Estrogen and progesterone receptors in the organs of prenatal cynomolgus monkey and laboratory mouse. Biol Reprod 1986;35:633–40
  • Stanczyk FZ, Hapgood JP, Winer S, et al. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev 2013;34:171–208
  • Noé G, Sitruk-Ware R, Zegers-Hochschild F, et al. Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women. Climacteric 2010;13:433–41
  • Nath A, Sitruk-Ware R. Parenteral administration of progestins for hormonal replacement therapy. Eur J Contracept Reprod Health Care 2009;14:88–96
  • Massai R, Quinteros E, Reyes MV, et al. Extended use of a progesterone-releasing vaginal ring in nursing women: a phase II clinical trial. Contraception 2005;72:352–7
  • Crinone® 4% and Crinone® 8% (progesterone gel) [package insert]. https://www.allergan.com/assets/pdf/crinone_pi. 2017
  • Endometrin® (progesterone) Vaginal Insert [package insert]. http://www.ferringusa.com/wp-content/uploads/2018/04/Endometrin-PI-01-2018.pdf
  • Thind KK, Goldsmith PC. Expression of estrogen and progesterone receptors in glutamate and GABA neurons of the pubertal female monkey hypothalamus. Neuroendocrinology 1997;65:314–24
  • Szabo M, Kilen SM, Nho SJ, et al. Progesterone receptor A and B messenger ribonucleic acid levels in the anterior pituitary of rats are regulated by estrogen. Biol Reprod 2000;62:95–102
  • Heikinheimo O, Mahony MC, Gordon K, et al. Estrogen and progesterone receptor mRNA are expressed in distinct pattern in male primate reproductive organs. J Assist Reprod Genet 1995;12:198–204
  • Luetjens CM, Didolkar A, Kliesch S, et al. Tissue expression of the nuclear progesterone receptor in male non-human primates and men. J Endocrinol 2006;189:529–39
  • Wadsworth PF, Heywood R, Allen DG, et al. Treatment of rhesus monkeys (Macaca mulatta) with intravaginal rings impregnated with either progesterone or norethisterone. Contraception 1979;20:339–51
  • Mannino CA, South SM, Inturrisi CE, et al. Pharmacokinetics and effects of 17beta-estradiol and progesterone implants in ovariectomized rats. J Pain 2005;6:809–16
  • Hudson R, Hempill P, Tillson SA. Preclinical evaluation of intrauterine progesterone as a contraceptive agent. I. Local contraceptive effects and their reversal. Contraception 1978;17:465–74
  • Coyle IR, Anker R, Cragg B. Behavioral, biochemical and histological effects of prenatal administration of progesterone in the rat. Pharmacol Biochem Behav 1976;5:587–90
  • Fulper LD, Cleary RW, Harland EC, et al. Comparison of serum progesterone levels in dogs after administration of progesterone by vaginal tablet and vaginal suppositories. Am J Obstet Gynecol 1987;156:253–6
  • Scott-Moncrieff JC, Nelson RW, Bill RL, et al. Serum disposition of exogenous progesterone after intramuscular administration in bitches. Am J Vet Res 1990;51:893–5
  • Gangrade NK, Boudinot FD, Price JC. Pharmacokinetics of progesterone in ovariectomized rats after single dose intravenous administration. Biopharm Drug Dispos 1992;13:703–9
  • Fang SM, Lin CS, Lyon V. Progesterone retention by rat uterus. I. Pharmacokinetics after uterine intraluminal instillation. J Pharm Sci 1977;66:1744–8
  • Kowalski WB, Chatterton RT, Jr, Kazer RR, et al. Disappearance and unexpected reappearance of progesterone in the circulation of the monkey: novel hormone kinetics. J Physiol 1996;493:877–84
  • Sitruk-Ware R, Ramarao S, Merkatz R, et al. Risk of pregnancy in breastfeeding mothers: role of the progesterone vaginal ring on birth spacing. EMJ Reprod Health 2016;2:66–72
  • Zegers-Hochschild F, Balmaceda JP, Fabres C, et al. Prospective randomized trial to evaluate the efficacy of a vaginal ring releasing progesterone for IVF and oocyte donation. Hum Reprod 2000;15:2093–7
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluations of Carcinogenic Risk of Chemicals to Man, Supplement 7, Overall evaluation of carcinogenicity: an update of IARC monographs volumes 1 to 42: progestins, combined oral contraceptives. Report No: Supplement 7. International Agency for Research on Cancer (IARC): 1987, 289
  • National Toxicology Program. Report on Carcinogens. Report No: Eleventh Edition. United States Department of Health and Human Services: 2005
  • Progestational drug products for human use; requirements for labeling directed to the patient. Fed Regist 1999;64:62110–12
  • Golub MS, Kaufman FL, Campbell MA, et al. Evidence on the developmental and reproductive toxicity of progesterone. Draft. Reproductive and Cancer Hazard Assessment Section. Office of Environmental Health Hazard Assessment, California Environmental Protection Agency: Aug 2004
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluations of Carcinogenic Risk of Chemicals to Man, Progesterone: Summary of data reported and evaluation. Report No: 21. International Agency for Research on Cancer (IARC): 1979, 135
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluations of Carcinogenic Risk of Chemicals to Man, Progesterone: Summary of data reported and evaluation. Report No: 6. International Agency for Research on Cancer (IARC): 1974, 135
  • Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 1996;104:938–67
  • Kordon EC, Molinolo AA, Pasqualini CD, et al. Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology. Breast Cancer Res Treat 1993;28:29–39
  • Rajkumar L, Guzman RC, Yang J, et al. Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. Breast Cancer Res 2004;6:R31–7
  • Guzman RC, Yang J, Rajkumar L, et al. Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci U S A 1999;96:2520–5
  • Dunkel VC, Zeiger E, Brusick D, et al. Reproducibility of microbial mutagenicity assays. II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and Escherichia coli. Environ Mutagen 1985;7(Suppl 5):1–248
  • Myhr BC, Caspary WJ. Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: intra-laboratory results for sixty-three coded chemicals tested at Litton Bionetics, Inc. Environ Mol Mutagen 1988;12(Suppl 13):103–94
  • Piotrowski J. The effect of progesterone on the foetal development of rats on the Wistar strain. Part 3. Folia Biol (Krakow) 1968;16:343–53
  • Piotrowski J. Experimental investigations on the effect of progesterone on embryonal development. Part II. Investigations carried out on rabbits. Folia Biol (Krakow) 1968;16:335–42
  • Wagner CK, Kinsley C, Svare B. Mice: postpartum aggression is elevated following prenatal progesterone exposure. Horm Behav 1986;20:212–21
  • Hendrickx AG, Korte R, Leuschner F, et al. Embryotoxicity of sex steroidal hormone combinations in nonhuman primates: I. Norethisterone acetate + ethinylestradiol and progesterone + estradiol benzoate (Macaca mulatta, Macaca fascicularis, and Papio cynocephalus)). Teratology 1987;35:119–27
  • Hendrickx AG, Korte R, Leuschner F, et al. Embryotoxicity of sex steroidal hormones in nonhuman primates: II. Hydroxyprogester-one caproate, estradiol valerate. Teratology 1987;35:129–36
  • Foote WD, Foote WC, Foote LH. Influence of certain natural and synthetic steroids on genital development in guinea pigs. Fertil Steril 1968;19:606–15
  • Pointis G, Latreille MT, Richard MO, et al. Effect of natural progesterone treatment during pregnancy on fetal testosterone and sexual behavior of the male offspring in the mouse. Dev Pharmacol Ther 1987;10:385–92
  • MacLusky NJ, McEwen BS. Oestrogen modulates progestin receptor concentrations in some rat brain regions but not in others. Nature 1978;274:276–8
  • Sandstrom NJ, Williams CL. Memory retention is modulated by acute estradiol and progesterone replacement. Behav Neurosci 2001;115:384–93
  • Robertson CL, Puskar A, Hoffman GE, et al. Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats. Exp Neurol 2006;197:235–43
  • Howard RB, Sayeed I, Stein DG. Suboptimal dosing parameters as possible factors in the negative phase III clinical trials of progesterone for traumatic brain injury. J Neurotrauma 2017;34:1915–18
  • Woolley CS, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 1993;336:293–306
  • Edwards HE, Epps T, Carlen PL, et al. Progestin receptors mediate progesterone suppression of epileptiform activity in tetanized hippocampal slices in vitro. Neuroscience 2000;101:895–906
  • Frye CA, Rhodes ME. Estrogen-priming can enhance progesterone's anti-seizure effects in part by increasing hippocampal levels of allopregnanolone . Pharmacol Biochem Behav 2005;81:907–16
  • Schumacher M, Guennoun R, Ghoumari A, et al. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr Rev 2007;28:387–439
  • Hussain R, El-Etr M, Gaci O, et al. Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors. Endocrinology 2011;152:3820–31
  • El-Etr M, Rame M, Boucher C, et al. Progesterone and Nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex. Glia 2015;63:104–17
  • Garay L, Gonzalez Deniselle MC, Sitruk-Ware R, et al. Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis. J Neuroimmunol 2014;276:89–97
  • Liu L, Zhao L, She H, et al. Clinical relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo. Endocrinology 2010;151:5782–4
  • Gibson CL, Murphy SP. Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice. J Cereb Blood Flow Metab 2004;24:805–13
  • Sayeed I, Wali B, Stein DG. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor Neurol Neurosci 2007;25:15–19
  • Gibson CL, Coomber B, Murphy SP. Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice. Brain 2011;134:2125–33
  • Sayeed I, Guo Q, Hoffman SW, et al. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann Emerg Med 2006;47:381–9
  • Liu A, Margaill I, Zhang S, et al. Progesterone receptors: a key for neuroprotection in experimental stroke. Endocrinology 2012;153:3747–57
  • Irwin RW, Solinsky CM, Loya CM, et al. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease. PLoS One 2015;10:e0128313
  • Irwin RW, Solinsky CM, Brinton RD. Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders. Front Cell Neurosci 2014;8:2–19
  • Irwin RW, Brinton RD. Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise. Prog Neurobiol 2014;113:40–55

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.